Astrazeneca's revenue surges as pipeline investments pay off
Astrazeneca has reported a jump in revenue for the first quarter of 2024 as partnerships paid off for the company in key markets.
Stay updated with breaking news from Pulmicort Flexhaler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Astrazeneca has reported a jump in revenue for the first quarter of 2024 as partnerships paid off for the company in key markets.
Strong growth and pipeline momentum with three new medicines approved since the third quarter ...
AstraZeneca reports strong FY and Q4 2023 results, with revenue growth, new medicine approvals, and optimistic growth projections for 2024.
Drug manufacturer GSK has discontinued Flovent asthma inhaler in favor of generics. The move could lead to some logistical headaches at the pharmacy, experts say.
FRIDAY, May 12, 2023 (HealthDay News) -- Receiving a diagnosis of asthma may be frightening, but learning what the treatment options are can help alleviate the anxiety that comes with